SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
46.51 EUR
-0.02 (-0.04%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 68 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.83%, SHL is doing good in the industry, outperforming 63.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.88%, SHL is in the better half of the industry, outperforming 67.69% of the companies in the same industry.
The Return On Invested Capital of SHL (7.66%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.73%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.66% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
The Profit Margin of SHL (9.17%) is better than 64.62% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
SHL's Operating Margin of 13.53% is in line compared to the rest of the industry. SHL outperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL has a worse Gross Margin (38.63%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SHL has been reduced compared to 1 year ago.
SHL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
SHL has an Altman-Z score of 2.10. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.10) is comparable to the rest of the industry.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
The Debt to FCF ratio of SHL (5.45) is comparable to the rest of the industry.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, SHL is doing worse than 66.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2.1 |
ROIC/WACC1.24
WACC6.19%
2.3 Liquidity
A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.11, SHL is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
A Quick Ratio of 0.79 indicates that SHL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, SHL is doing worse than 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
Measured over the past years, SHL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.29% on average per year.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.85% yearly.
The Revenue is expected to grow by 5.74% on average over the next years.
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y9.85%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.46, the valuation of SHL can be described as rather expensive.
86.15% of the companies in the same industry are more expensive than SHL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.19, SHL is valued a bit cheaper.
The Price/Forward Earnings ratio is 19.52, which indicates a rather expensive current valuation of SHL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 66.15% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (23.92), we can say SHL is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.46 | ||
| Fwd PE | 19.52 |
4.2 Price Multiples
SHL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SHL is cheaper than 66.15% of the companies in the same industry.
86.15% of the companies in the same industry are more expensive than SHL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.33 | ||
| EV/EBITDA | 14.44 |
4.3 Compensation for Growth
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.72
EPS Next 2Y6.49%
EPS Next 3Y8.77%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.15%, SHL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.13, SHL pays a better dividend. On top of this SHL pays more dividend than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
FRA:SHL (1/9/2026, 7:00:00 PM)
46.51
-0.02 (-0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap52.46B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts78.57
Price Target56.61 (21.72%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-0.51%
PT rev (3m)-8.52%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)-10.29%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-8.85%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.46 | ||
| Fwd PE | 19.52 | ||
| P/S | 2.24 | ||
| P/FCF | 19.33 | ||
| P/OCF | 14.85 | ||
| P/B | 2.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.44 |
EPS(TTM)2.39
EY5.14%
EPS(NY)2.38
Fwd EY5.12%
FCF(TTM)2.41
FCFY5.17%
OCF(TTM)3.13
OCFY6.73%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)N/A
PEG (5Y)1.72
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.66% | ||
| ROICexc | 8.32% | ||
| ROICexgc | 43.55% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.21% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.1 |
F-Score8
WACC6.19%
ROIC/WACC1.24
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y9.85%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.74%
EBIT growth 1Y12.56%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year34.58%
EBIT Next 3Y17.72%
EBIT Next 5Y14.4%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
Can you provide the valuation status for SIEMENS HEALTHINEERS AG?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 19.46 and the Price/Book (PB) ratio is 2.91.
How financially healthy is SIEMENS HEALTHINEERS AG?
The financial health rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 3 / 10.